• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿柔比星(一种蒽环类衍生物)在人白血病HL60细胞和单核细胞中的转运机制及其与其类似物转运机制的比较。

Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs.

作者信息

Nagasawa K, Ohnishi N, Yokoyama T

机构信息

Department of Hospital Pharmacy, Faculty of Pharmaceutical Sciences, Kyoto Pharmaceutical University.

出版信息

Jpn J Cancer Res. 1997 Aug;88(8):750-9. doi: 10.1111/j.1349-7006.1997.tb00447.x.

DOI:10.1111/j.1349-7006.1997.tb00447.x
PMID:9330607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5921500/
Abstract

Transport mechanisms of idarubicin (IDA) in HL60 cells, as leukemia cells, and human mononuclear cells (MNCs), as normal cells, were investigated, and compared with those of its analogs. The uptake of IDA by both cell types was temperature- and concentration-dependent, was inhibited competitively by daunorubicin (DNR) and noncompetitively by adriamycin (ADR), and was stimulated by preloading of the cells with DNR and ADR, indicating the partial involvement of a carrier-mediated mechanism. On pretreatment of the cells with 2,4-dinitrophenol, IDA uptake by HL60 cells increased, but that by MNCs decreased, suggesting that IDA was partially taken up into HL60 cells via an energy-independent carrier system, and into MNCs via an energy-dependent one. We speculated that in HL60 cells the carrier concerned with IDA uptake was common to DNR and ADR, and that the binding site of IDA on the carrier was the same as that for DNR, but not that for ADR, while in MNCs the carrier system consisted of, at least in part, a carrier for DNR uptake and one for ADR uptake, and the binding site of IDA was identical to that for DNR in the former, but different from that for ADR in the latter. It appeared that the uptake of IDA was greater than those of pirarubicin, DNR and ADR in both HL60 cells and MNCs, and that IDA was incorporated into MNCs more efficiently than into HL60 cells because of the higher uptake efficacy of the carrier(s).

摘要

研究了白血病细胞HL60细胞和正常细胞人单核细胞(MNCs)中伊达比星(IDA)的转运机制,并将其与其类似物的转运机制进行了比较。两种细胞类型对IDA的摄取均呈温度和浓度依赖性,受柔红霉素(DNR)竞争性抑制,受阿霉素(ADR)非竞争性抑制,并且通过用DNR和ADR预加载细胞可刺激摄取,表明部分涉及载体介导的机制。用2,4-二硝基苯酚预处理细胞后,HL60细胞对IDA的摄取增加,但MNCs对IDA的摄取减少,这表明IDA部分通过能量非依赖性载体系统进入HL60细胞,部分通过能量依赖性载体系统进入MNCs。我们推测,在HL60细胞中,与IDA摄取相关的载体对DNR和ADR是通用的,并且IDA在载体上的结合位点与DNR相同,但与ADR不同,而在MNCs中,载体系统至少部分由用于DNR摄取的载体和用于ADR摄取的载体组成,并且IDA的结合位点在前者中与DNR相同,但在后者中与ADR不同。似乎在HL60细胞和MNCs中,IDA的摄取均大于吡柔比星、DNR和ADR的摄取,并且由于载体的摄取效率较高,IDA进入MNCs的效率高于进入HL60细胞的效率。

相似文献

1
Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs.阿柔比星(一种蒽环类衍生物)在人白血病HL60细胞和单核细胞中的转运机制及其与其类似物转运机制的比较。
Jpn J Cancer Res. 1997 Aug;88(8):750-9. doi: 10.1111/j.1349-7006.1997.tb00447.x.
2
Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.核苷转运系统对阿霉素在HL60细胞而非单核细胞中的转运作用。
Jpn J Cancer Res. 1999 Jul;90(7):781-7. doi: 10.1111/j.1349-7006.1999.tb00815.x.
3
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
Biol Pharm Bull. 1996 Jan;19(1):100-5. doi: 10.1248/bpb.19.100.
4
Transport mechanism of pirarubicin in human mononuclear cells.
Biol Pharm Bull. 1996 Sep;19(9):1203-9. doi: 10.1248/bpb.19.1203.
5
Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Biol Pharm Bull. 1996 Jul;19(7):971-6. doi: 10.1248/bpb.19.971.
6
Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.核苷转运系统可能参与吡柔比星被HL60细胞而非单核细胞摄取的过程。
Jpn J Cancer Res. 1998 Jun;89(6):673-80. doi: 10.1111/j.1349-7006.1998.tb03270.x.
7
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.蒽环类衍生物在人白血病细胞系中的转运机制:吡柔比星在HL60细胞及吡柔比星耐药HL60细胞中的摄取与外排
Cancer Chemother Pharmacol. 1996;37(4):297-304. doi: 10.1007/s002800050389.
8
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.伊达比星、柔红霉素及其C-13醇代谢产物对转运介导的多药耐药性的敏感性。
Biochem Pharmacol. 1995 Nov 9;50(10):1673-83. doi: 10.1016/0006-2952(95)02069-1.
9
Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.伊达比星与柔红霉素在细胞内摄取、凋亡诱导及耐药性方面的比较。
Cancer Lett. 2002 Apr 25;178(2):141-9. doi: 10.1016/s0304-3835(01)00824-2.
10
Comparison of uptake mechanisms for anthracyclines in human leukemic cells.蒽环类抗生素在人白血病细胞中的摄取机制比较。
Curr Drug Deliv. 2013 Aug;10(4):404-12. doi: 10.2174/1567201811310040005.

引用本文的文献

1
Kinetic analysis of saturable myocardial uptake of idarubicin in rat heart: effect of doxorubicin and hypothermia.伊达比星在大鼠心脏中饱和性心肌摄取的动力学分析:多柔比星和低温的影响
Pharm Res. 2003 Jan;20(1):58-63. doi: 10.1023/a:1022246708326.
2
Caffeine enhances myocardial uptake of idarubicin but reverses its negative inotropic effect.
Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):151-5. doi: 10.1007/s00210-002-0683-2. Epub 2003 Jan 23.
3
Effects of 1-methyl-3-propyl-7-butylxanthine (MPBX) on idarubicin-induced antitumor activity and bone marrow suppression.1-甲基-3-丙基-7-丁基黄嘌呤(MPBX)对伊达比星诱导的抗肿瘤活性和骨髓抑制的影响。
Jpn J Cancer Res. 2000 Jun;91(6):651-7. doi: 10.1111/j.1349-7006.2000.tb00995.x.
4
Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.核苷转运系统对阿霉素在HL60细胞而非单核细胞中的转运作用。
Jpn J Cancer Res. 1999 Jul;90(7):781-7. doi: 10.1111/j.1349-7006.1999.tb00815.x.
5
Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.吡柔比星的膜转运与抗肿瘤活性及其与多柔比星的比较
Jpn J Cancer Res. 1999 Jul;90(7):775-80. doi: 10.1111/j.1349-7006.1999.tb00814.x.
6
Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.核苷转运系统可能参与吡柔比星被HL60细胞而非单核细胞摄取的过程。
Jpn J Cancer Res. 1998 Jun;89(6):673-80. doi: 10.1111/j.1349-7006.1998.tb03270.x.

本文引用的文献

1
Transport mechanism of pirarubicin in human mononuclear cells.
Biol Pharm Bull. 1996 Sep;19(9):1203-9. doi: 10.1248/bpb.19.1203.
2
Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Biol Pharm Bull. 1996 Jul;19(7):971-6. doi: 10.1248/bpb.19.971.
3
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
Biol Pharm Bull. 1996 Jan;19(1):100-5. doi: 10.1248/bpb.19.100.
4
Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells.伊达比星和柔红霉素及其主要代谢产物在细胞内摄取以及对敏感和多药耐药HL60细胞影响方面的比较。
Cancer Chemother Pharmacol. 1996;38(5):476-80. doi: 10.1007/s002800050514.
5
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin.
Cancer Chemother Pharmacol. 1996;38(5):439-45. doi: 10.1007/s002800050508.
6
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.新型蒽环类抗生素安那霉素不受P-糖蛋白相关多药耐药性的影响:在HL-60白血病细胞系中与伊达比星和多柔比星的比较。
Blood. 1996 Jul 15;88(2):633-44.
7
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.一项关于伊达比星与柔红霉素用于55至75岁年龄组急性髓性白血病联合化疗的前瞻性随机试验。
Leukemia. 1996 Mar;10(3):389-95.
8
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.蒽环类衍生物在人白血病细胞系中的转运机制:吡柔比星在HL60细胞及吡柔比星耐药HL60细胞中的摄取与外排
Cancer Chemother Pharmacol. 1996;37(4):297-304. doi: 10.1007/s002800050389.
9
Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.柔红霉素衍生物伊达比星对药物敏感和耐药的P388白血病的抗肿瘤活性。
Anticancer Res. 1993 Mar-Apr;13(2):357-61.
10
Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.
Int J Hematol. 1993 Apr;57(2):121-30.